ANPAC BIO-MEDICAL SCIENC-ADR (ANPC)

US03635R2067 - ADR

4.37  -0.25 (-5.41%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021
Revenue
YoY % growth
10.85M
5.85%
20.51M
89.03%
17.986M
-12.31%
EBITDA
YoY % growth
-86.42M
-113.54%
-90.03M
-4.18%
-102.136M
-13.45%
EBIT
YoY % growth
-89.08M
-104.27%
-93.13M
-4.55%
-106.046M
-13.87%
Operating Margin
-821.01%-454.07%-589.60%
EPS
YoY % growth
N/AN/AN/A

All data in CNY

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CNY

Recent Earnings VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth
4.306M
-73.84%
1.948M2.358M121.05%
Q3 2021
Q2Q % growth
4.424M 1.676M2.748M163.96%
Q2 2021
Q2Q % growth
7.071M
74.55%
1.548M5.523M356.78%
Q4 2020
Q2Q % growth
16.46M
502.93%
1.326M15.134M1,141.33%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A